News
The NHS will roll out a new treatment for advanced bladder cancer which doubles survival time. It's estimated that 1,250 ...
Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit ...
A new treatment for advanced bladder cancer which doubles survival time has been given the green light for NHS use.
MDMA (Molly, ecstasy) is an empathogen widely used as a club drug that may become a future treatment for PTSD. Many respond ...
1d
Stocktwits on MSNCSX, Intel, Palantir, Nvidia, Merck: What Sparked Heavy After-Hours Trading In These 5 Stocks?
Tech rout led to another session of weakness on Wall Street on Tuesday as heavily-weighted Nvidia (NVA), peer AMD (AMD), and ...
1d
MedPage Today on MSNAI-Enabled Diabetes System Helps Patients Lower A1c
The AI-enabled bundled system used sensors and coaching to guide patients. It generated personalized recommendations by ...
The FDA granted breakthrough therapy designation to Ifinatamab deruxtecan for some with extensive-stage small cell lung ...
Merck’s strong oncology gains, 4% yield, and low PEG ratio support its value case despite sector risks and patent concerns.
EdiMembre has spun off from Merck Group to commercialise its edible membrane tech for future foods, starting with whole-cut ...
New Jersey officials are eyeing several efforts, including a massive $500 million incentive program meant to entice more products to be "Made in NJ." ...
New research shows that people with dementia experience faster memory decline if they’re also diagnosed with inflammatory bowel disease (IBD).
Janux Therapeutics Inc. (NASDAQ:JANX) is a clinical-stage biopharmaceutical company that develops immunotherapies based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results